Polarization of protective immunity induced by replication-incompetent adenovirus expressing glycoproteins of pseudorabies virus

Experimental and Molecular Medicine

Volumn 40, Issue 6, 2008, Pages 583-595

  Young, Woo Han ^a   Aleyas, Abi G ^a   George, Junu A ^a   Seon, Ju Kim ^a   Hye, Kyung Kim ^a   Hyun, A Yoon ^a   Dong, Jin Yoo ^b   Seong, Ho Kang ^a   Kim, Koanhoi ^c   Seong, Kug Eo ^a  

^a Chonbuk National University   (South Korea)

^b Seonam University   (South Korea)

^c Pusan National University School of Medicine   (South Korea)

Author keywords

Adenoviruses, human; Herpesvirus 1, suid; Th1 cells; Th2 cells; Vaccination

Indexed keywords

GAMMA INTERFERON; GLYCOPROTEIN B; GLYCOPROTEIN D; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 2; PROTEIN C;

ADENOVIRUS; ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PSEUDORABIES HERPETOVIRUS; TH1 CELL; TH2 CELL; VIRUS INFECTION;

ADENOVIRIDAE; HUMAN HERPESVIRUS 1; SUID HERPESVIRUS 1; SUIDAE;

EID: 61849162800     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.3858/emm.2008.40.6.583     Document Type: Article

References (40)

1. Ali M, Lemoine NR, Ring CJ. The use of DNA viruses as vectors for gene therapy. Gene therapy 1994;1:367-84
2. Ambriovic A, Adam M, Monteil M, Paulin D, Eloit M. Efficacy of replication-defective adenovirus-vectored vaccines: protection following intramuscular injection is linked to promoter efficiency in muscle representative cells. Virology 1997;238:327-35
3. Babiuk LA, Tikoo SK. Adenoviruses as vectors for delivering vaccines to mucosal surfaces. Journal of biotechnology 2000;83:105-13
4. Barouch DH, Nabel GJ. Adenovirus vector-based vaccines for human immunodeficiency virus type 1. Human gene therapy 2005;16:149-56
5. Bianchi AT, Moonen-Leusen HW, van Milligen FJ, Savelkoul HF, Zwart RJ, Kimman TG. A mouse model to study immunity against pseudorabies virus infection: significance of CD4+ and CD8+ cells in protective immunity. Vaccine 1998;16:1550-8
6. Davis HL, Demeneix BA, Quantin B, Coulombe J, Whalen RG. Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. Human gene therapy 1993;4:733-40
7. Davis SS. Nasal vaccines. Advanced drug delivery reviews 2001;51:21-42
8. Eloit M, Adam M. Isogenic adenoviruses type 5 expressing or not expressing the E1A gene: efficiency as virus vectors in the vaccination of permissive and non-permissive species. The Journal of general virology 1995;76 (Pt 7):1583-9
9. Eo SK, Lee S, Chun S, Rouse BT. Modulation of immunity against herpes simplex virus infection via mucosal genetic transfer of plasmid DNA encoding chemokines. Journal of virology 2001;75:569-78
10. Fischer T, Buttner M, Rziha HJ. T helper 1-type cytokine transcription in peripheral blood mononuclear cells of pseudorabies virus (Suid herpesvirus 1)-primed swine indicates efficient immunization. Immunology 2000;101:378-87
11. Gonin P, Oualikene W, Fournier A, Eloit M. Comparison of the efficacy of replication-defective adenovirus and Nyvac poxvirus as vaccine vectors in mice. Vaccine 1996;14:1083-7
12. Hong W, Xiao S, Zhou R, Fang L, He Q, Wu B, Zhou F, Chen H. Protection induced by intramuscular immunization with DNA vaccines of pseudorabies in mice, rabbits and piglets. Vaccine 2002;20:1205-14
13. Howarth M, Elliott T. The processing of antigens delivered as DNA vaccines. Immunological reviews 2004;199:27-39
14. Khanam S, Rajendra P, Khanna N, Swaminathan S. An adenovirus prime/plasmid boost strategy for induction of equipotent immune responses to two dengue virus serotypes. BMC biotechnology 2007;7:10
15. Kit S. Safety, efficacy of genetically engineered Aujeszky's disease vaccines. In Vaccination and Control of Aujeszky's Disease (Oirschot T. J. V., ed), 1988, 45-55, Kluwer Academic Publishers, Dordercht
16. Klinman DM. Adjuvant activity of CpG oligodeoxynucleotides. International reviews of immunology 2006;25:135-54
17. Kluge JP, Beran G, Hill GT, Platt KB. Pseudorabies (Aujeszky's Disease). In Disease of Swine (B. E. Straw S. D. A., W. L. Mengeling, D. J Taylor, eds), 1999, 233-246, State University Press, Ames, IA
18. La S, Kim E, Kwon B. In vivo ligation of glucocorticoid-induced TNF receptor enhances the T-cell immunity to herpes simplex virus type 1. Experimental & molecular medicine 2005;37:193-8
19. Liu Y, Okada T, Nomoto T, Ke X, Kume A, Ozawa K, Xiao S. Promoter effects of adeno-associated viral vector for transgene expression in the cochlea in vivo. Experimental & Molecular Medicine 2007;39:170-5
20. Mettenleiter TC. Immunobiology of pseudorabies (Aujeszky's disease). Veterinary immunology and immunopathology 1996;54:221-9
21. Mizuguchi H, Hayakawa T. Targeted adenovirus vectors. Human gene therapy 2004;15:1034-44
22. Monteil M, Le Potier MF, Cariolet R, Houdayer C, Eloit M. Effective priming of neonates born to immune dams against the immunogenic pseudorabies virus glycoprotein gD by replication-incompetent adenovirus-mediated gene transfer at birth. The Journal of general virology 1997;78 (Pt 12):3303-10
23. Monteil M, Le Pottier MF, Ristov AA, Cariolet R, L'Hospitalier R, Klonjkowski B, Eloit M. Single inoculation of replication-defective adenovirus-vectored vaccines at birth in piglets with maternal antibodies induces high level of antibodies and protection against pseudorabies. Vaccine 2000;18:1738-42
24. Ober BT, Summerfield A, Mattlinger C, Wiesmuller KH, Jung G, Pfaff E, Saalmuller A, Rziha HJ. Vaccine-induced, pseudorabies virus-specific, extrathymic CD4+CD8+ memory T-helper cells in swine. Journal of Virology 1998;72:4866-73
25. Ober BT, Teufel B, Wiesmuller KH, Jung G, Pfaff E, Saalmuller A, Rziha HJ. The porcine humoral immune response against pseudorabies virus specifically targets attachment sites on glycoprotein gC. Journal of Virology 2000;74:1752-60
26. Parr MB, Harriman GR, Parr EL. Immunity to vaginal HSV-2 infection in immunoglobulin A knockout mice. Immunology 1998;95:208-13
27. Plog MS, Guyre CA, Roberts BL, Goldberg M, St George JA, Perricone MA. Preclinical safety and biodistribution of adenovirus-based cancer vaccines after intradermal delivery. Human Gene Therapy 2006;17:705-16
28. Randrianarison-Jewtoukoff V, Perricaudet M. Recombinant adenoviruses as vaccines. Biologicals 1995;23:145-57
29. Rocha CD, Caetano BC, Machado AV, Bruna-Romero O. Recombinant viruses as tools to induce protective cellular immunity against infectious diseases. Int Microbiol 2004;7:83-94
30. Shedlock DJ, Weiner DB. DNA vaccination: antigen presentation and the induction of immunity. Journal of Leukocyte Biology 2000;68:793-806
31. Shiver JW, Fu TM, Chen L, Casimiro DR, Davies ME, Evans RK, Zhang ZQ, Simon AJ, Trigona WL, Dubey SA, Huang L, Harris VA, Long RS, Liang X, Handt L, Schleif WA, Zhu L, Freed DC, Persaud NV, Guan L, Punt KS, Tang A, Chen M, Wilson KA, Collins KB, Heidecker GJ, Fernandez VR, Perry HC, Joyce JG, Grimm KM, Cook JC, Keller PM, Kresock DS, Mach H, Troutman RD, Isopi LA, Williams DM, Xu Z, Bohannon KE, Volkin DB, Montefiori DC, Miura A, Krivulka GR, Lifton MA, Kuroda MJ, Schmitz JE, Letvin NL, Caulfield MJ, Bett AJ, Youil R, Kaslow DC, Emini EA. Replicationin-competent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 2002;415:331-5
32. Suzuki Y, Kagawa N, Fujino T, Sumiya T, Andoh T, Ishikawa K, Kimura R, Kemmochi K, Ohta T, Tanaka S. A novel high-throughput (HTP) cloning strategy for site-directed designed chimeragenesis and mutation using the Gateway cloning system. Nucleic Acids Research 2005;33:e109
33. van Rooij EM, Haagmans BL, de Visser YE, de Bruin MG, Boersma W, Bianchi AT. Effect of vaccination route and composition of DNA vaccine on the induction of protective immunity against pseudorabies infection in pigs. Veterinary Immunology and Immunopathology 1998;66:113-26
34. van Rooij EM, Haagmans BL, Glansbeek HL, de Visser YE, de Bruin MG, Boersma W, Bianchi AT. A DNA vaccine coding for glycoprotein B of pseudorabies virus induces cell-mediated immunity in pigs and reduces virus excretion early after infection. Veterinary Immunology and Immunopathology 2000;74:121-36
35. van Rooij EM, de Bruin MG, de Visser YE, Middel WG, Boersma WJ, Bianchi AT. Vaccine-induced T cell-mediated immunity plays a critical role in early protection against pseudorabies virus (suid herpes virus type 1) infection in pigs. Veterinary Immunology and Immunopathology 2004;99:113-25
36. Walhout AJ, Temple GF, Brasch MA, Hartley JL, Lorson MA, van den Heuvel S, Vidal M. GATEWAY recombinational cloning: application to the cloning of large numbers of open reading frames or ORFeomes. Methods in Enzymology 2000;328:575-92
37. Wesley RD, Tang M, Lager KM. Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus. Vaccine 2004;22:3427-34
38. Yoon HA, Aleyas AG, George JA, Park SO, Han YW, Kang SH, Cho JG, Eo SK. Differential segregation of protective immunity by encoded antigen in DNA vaccine against pseudorabies virus. Immunology and Cell Biology 2006;84:502-11
39. Zaripov MM, Morenkov OS, Siklodi B, Barna-Vetro I, Gyongyosi-Horvath A, Fodor I. Glycoprotein B of Aujeszky's disease virus: topographical epitope mapping and epitope-specific antibody response. Research in Virology 1998;149:29-41
40. Zaripov MM, Morenkov OS, Fodor N, Braun A, Schmatchenko VV, Fodor I. Distribution of B-cell epitopes on the pseudorabies virus glycoprotein B. The Journal of General Virology 1999;80 (Pt 3):537-41